BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3727521)

  • 1. [Criteria for evaluation of the efficacy of immunotherapy of bronchiectasis patients].
    Gubergrits AIa; Monogarova NE; Sokhin AA
    Vrach Delo; 1986 May; (5):89-91. PubMed ID: 3727521
    [No Abstract]   [Full Text] [Related]  

  • 2. [Levamisole and splenin in combined therapy of patients with bronchiectasis].
    Sokhin AA; Monogarova NE; Zeligman VS; Chernykh SN; Radugina GS
    Klin Med (Mosk); 1989 Sep; 67(9):38-41. PubMed ID: 2586038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R
    Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer].
    Kikot' VA; Dziubko NIa
    Vrach Delo; 1989 Jul; (7):46-8. PubMed ID: 2800496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopoietin and levamisole in chronic granulomatous inflammation.
    Thrower PA; Sedgwick AD; Smith ER; Willoughby DA; Huskisson EC
    Ann Rheum Dis; 1983 Feb; 42(1):94-7. PubMed ID: 6830330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy of breast cancer patients].
    Korolev VI; Bendiug GD; Dziubko NiA ; Ponomarev IN; Krivorotov AA
    Vrach Delo; 1987 Jun; (6):90-3. PubMed ID: 3630094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of splenin and zymosan on the immune system of patients with a soft tissue sarcoma].
    Dziubko NIa; Tolstopiatov BA; Konovalenko VF; Chernenko OD; Redkousova SF
    Vrach Delo; 1987 Jul; (7):81-3. PubMed ID: 2442892
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymopoietin in rheumatoid arthritis.
    Thrower PA; Doyle DV; Scott J; Huskisson EC
    Rheumatol Rehabil; 1982 May; 21(2):72-7. PubMed ID: 7043711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of splenin in the combined treatment of pulmonary tuberculosis patients].
    Spesivtsev OG; Gal'chanskaia LD; Sobolevskaia LI; Prosvetov IuV
    Probl Tuberk; 1985; (8):28-31. PubMed ID: 4059204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of the effectiveness of immuno-correcting therapy in insulin-dependent diabetes mellitus in children].
    Kravets EB
    Pediatriia; 1990; (6):18-21. PubMed ID: 2395617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thymopentin treatment of ovarian carcinoma: preliminary clinical results].
    Garozzo G; GranĂ  G; Lomeo E; La Greca M; Castiglione MG; Caruso M; Curatolo M; Gurgone P
    G Ital Oncol; 1988; 8(1):11-3. PubMed ID: 3065223
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological reactivity of patients with suppurative lung diseases and the effectiveness of immunocorrective therapy].
    Gubergrits AIa; Sokhin AA; Monogarova NE; Kurilova VG
    Ter Arkh; 1985; 57(3):55-8. PubMed ID: 3873719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and tolerability of thymopoietin in patients at risk of infection].
    Recenti Prog Med; 1987; 78(7-8):358-64. PubMed ID: 3321257
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in histamine metabolism during treatment of hepatitis B patients with splenin].
    Mitchenko IK; Slobodianiuk MI; Degtiarenko OM; Shevchenko AV; Tiuleneva GV
    Vrach Delo; 1984 May; (5):120-1. PubMed ID: 6741074
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunomodulators in the treatment of rheumatoid arthritis. II. Comparative clinical efficacy of levamisole (dekaris) and thymalin].
    Melekhin VD; Siniachenko VV; Leshchenko GIa; Morozov VG; Khavinson VKh
    Revmatologiia (Mosk); 1985; (4):25-8. PubMed ID: 3912890
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of thymopentin in the therapy of recurrent oral ulcers].
    Robotti MP; Fabbri G; Baldin C; Faccioli G; Ciaffoni S
    Minerva Stomatol; 1988 Jun; 37(6):497-503. PubMed ID: 3050443
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of splenin for the purpose of immunocorrection in patients with seroresistance following syphilis treatment].
    Bakhmet'eva TM; Lonshakov IuI; Petrova IV
    Vestn Dermatol Venerol; 1988; (10):38-42. PubMed ID: 3223051
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possible selective effects of thymopentin on polymorphonuclear activity in patients undergoing dialysis].
    Salvati F
    Recenti Prog Med; 1989 Sep; 80(9):499. PubMed ID: 2687987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of recurrent oral aphthae with thymopoetin pentapeptide].
    Djawari D; Haneke E
    Hautarzt; 1983 Sep; 34(9):463-4. PubMed ID: 6355012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro system for determining the use of immunocorrective agents in patients with disseminated psoriasis].
    Vasil'eva LL; Amirova IA
    Vestn Dermatol Venerol; 1984 Oct; (10):6-8. PubMed ID: 6334943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.